These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 15688409)
21. The alveolar rhabdomyosarcoma PAX3/FKHR fusion protein is a transcriptional activator. Sublett JE; Jeon IS; Shapiro DN Oncogene; 1995 Aug; 11(3):545-52. PubMed ID: 7630639 [TBL] [Abstract][Full Text] [Related]
22. The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3. Fredericks WJ; Galili N; Mukhopadhyay S; Rovera G; Bennicelli J; Barr FG; Rauscher FJ Mol Cell Biol; 1995 Mar; 15(3):1522-35. PubMed ID: 7862145 [TBL] [Abstract][Full Text] [Related]
23. Investigation of PAX3/7-FKHR fusion genes and IGF2 gene expression in rhabdomyosarcoma tumors. de Souza RR; Oliveira ID; Caran EM; Alves MT; Abib S; Toledo SR Growth Horm IGF Res; 2012 Dec; 22(6):245-9. PubMed ID: 23079386 [TBL] [Abstract][Full Text] [Related]
24. Analysis of the transforming and growth suppressive activities of the PAX3-FKHR oncoprotein. Xia SJ; Barr FG Oncogene; 2004 Sep; 23(41):6864-71. PubMed ID: 15286710 [TBL] [Abstract][Full Text] [Related]
25. Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas. Laé M; Ahn EH; Mercado GE; Chuai S; Edgar M; Pawel BR; Olshen A; Barr FG; Ladanyi M J Pathol; 2007 Jun; 212(2):143-51. PubMed ID: 17471488 [TBL] [Abstract][Full Text] [Related]
26. Minimal disease detection in patients with alveolar rhabdomyosarcoma using a reverse transcriptase-polymerase chain reaction method. Kelly KM; Womer RB; Barr FG Cancer; 1996 Sep; 78(6):1320-7. PubMed ID: 8826957 [TBL] [Abstract][Full Text] [Related]
27. Pax3:Fkhr interferes with embryonic Pax3 and Pax7 function: implications for alveolar rhabdomyosarcoma cell of origin. Keller C; Hansen MS; Coffin CM; Capecchi MR Genes Dev; 2004 Nov; 18(21):2608-13. PubMed ID: 15520281 [TBL] [Abstract][Full Text] [Related]
28. The oncogenic potential of the Pax3-FKHR fusion protein requires the Pax3 homeodomain recognition helix but not the Pax3 paired-box DNA binding domain. Lam PY; Sublett JE; Hollenbach AD; Roussel MF Mol Cell Biol; 1999 Jan; 19(1):594-601. PubMed ID: 9858583 [TBL] [Abstract][Full Text] [Related]
29. Structural analysis of PAX7 rearrangements in alveolar rhabdomyosarcoma. Fitzgerald JC; Scherr AM; Barr FG Cancer Genet Cytogenet; 2000 Feb; 117(1):37-40. PubMed ID: 10700864 [TBL] [Abstract][Full Text] [Related]
30. Normal and rearranged PAX3 expression in human rhabdomyosarcoma. Frascella E; Toffolatti L; Rosolen A Cancer Genet Cytogenet; 1998 Apr; 102(2):104-9. PubMed ID: 9546061 [TBL] [Abstract][Full Text] [Related]
31. Pax3-fkhr and pax7-fkhr fusion genes impact outcome of alveolar rhabdomyosarcoma in children. Kazanowska B; Reich A; Stegmaier S; Békássy AN; Leuschner I; Chybicka A; Koscielniak E Fetal Pediatr Pathol; 2007; 26(1):17-31. PubMed ID: 17613043 [TBL] [Abstract][Full Text] [Related]
32. Validation of met as a therapeutic target in alveolar and embryonal rhabdomyosarcoma. Taulli R; Scuoppo C; Bersani F; Accornero P; Forni PE; Miretti S; Grinza A; Allegra P; Schmitt-Ney M; Crepaldi T; Ponzetto C Cancer Res; 2006 May; 66(9):4742-9. PubMed ID: 16651427 [TBL] [Abstract][Full Text] [Related]
33. Insulin-like growth factor II and PAX3-FKHR cooperate in the oncogenesis of rhabdomyosarcoma. Wang W; Kumar P; Wang W; Epstein J; Helman L; Moore JV; Kumar S Cancer Res; 1998 Oct; 58(19):4426-33. PubMed ID: 9766674 [TBL] [Abstract][Full Text] [Related]
34. Alternate PAX3 and PAX7 C-terminal isoforms in myogenic differentiation and sarcomagenesis. Charytonowicz E; Matushansky I; Castillo-Martin M; Hricik T; Cordon-Cardo C; Ziman M Clin Transl Oncol; 2011 Mar; 13(3):194-203. PubMed ID: 21421465 [TBL] [Abstract][Full Text] [Related]
35. Induction of apoptosis in rhabdomyosarcoma cells through down-regulation of PAX proteins. Bernasconi M; Remppis A; Fredericks WJ; Rauscher FJ; Schäfer BW Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13164-9. PubMed ID: 8917562 [TBL] [Abstract][Full Text] [Related]
36. Predominant expression of alternative PAX3 and PAX7 forms in myogenic and neural tumor cell lines. Barr FG; Fitzgerald JC; Ginsberg JP; Vanella ML; Davis RJ; Bennicelli JL Cancer Res; 1999 Nov; 59(21):5443-8. PubMed ID: 10554014 [TBL] [Abstract][Full Text] [Related]
37. [Influences of PAX3-FKHR transfection on expression of MRF4 and differentiation of cultured human rhabdomyosarcoma RD cells]. Li GH; Wang DL; Wang Y; Chen ZT; Li DZ Ai Zheng; 2003 Jan; 22(1):30-4. PubMed ID: 12561432 [TBL] [Abstract][Full Text] [Related]
38. Novel formation and amplification of the PAX7-FKHR fusion gene in a case of alveolar rhabdomyosarcoma. Weber-Hall S; McManus A; Anderson J; Nojima T; Abe S; Pritchard-Jones K; Shipley J Genes Chromosomes Cancer; 1996 Sep; 17(1):7-13. PubMed ID: 8889501 [TBL] [Abstract][Full Text] [Related]
40. Concomitant amplification and expression of PAX7-FKHR and MYCN in a human rhabdomyosarcoma cell line carrying a cryptic t(1;13)(p36;q14). Frascella E; Lenzini E; Schafer BW; Brecevic L; Dorigo E; Toffolatti L; Nanni P; De Giovanni C; Rosolen A Cancer Genet Cytogenet; 2000 Sep; 121(2):139-45. PubMed ID: 11063797 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]